111 related articles for article (PubMed ID: 27914514)
1. Protective effects of fish oil and pioglitazone on pancreatic tissue in obese KK mice with type 2 diabetes.
Iizuka Y; Kim H; Izawa T; Sakurai K; Hirako S; Wada M; Matsumoto A
Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():53-59. PubMed ID: 27914514
[TBL] [Abstract][Full Text] [Related]
2. Benefits of combination low-dose pioglitazone plus fish oil on aged type 2 diabetes mice.
Iizuka Y; Kim H; Hirako S; Chiba K; Wada M; Matsumoto A
J Food Drug Anal; 2018 Oct; 26(4):1265-1274. PubMed ID: 30249325
[TBL] [Abstract][Full Text] [Related]
3. Fish oil supplementation inhibits endoplasmic reticulum stress and improves insulin resistance: involvement of AMP-activated protein kinase.
Yang W; Chen X; Chen M; Li Y; Li Q; Jiang X; Yang Y; Ling W
Food Funct; 2017 Apr; 8(4):1481-1493. PubMed ID: 28327709
[TBL] [Abstract][Full Text] [Related]
4. Dietary combination of fish oil and taurine decreases fat accumulation and ameliorates blood glucose levels in type 2 diabetic/obese KK-A(y) mice.
Mikami N; Hosokawa M; Miyashita K
J Food Sci; 2012 Jun; 77(6):H114-20. PubMed ID: 22582992
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice.
Kawasaki F; Matsuda M; Kanda Y; Inoue H; Kaku K
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E510-8. PubMed ID: 15522998
[TBL] [Abstract][Full Text] [Related]
6. Fish oil and fenofibrate inhibit pancreatic islet hypertrophy, and improve glucose and lipid metabolic dysfuntions with different ways in diabetic KK mice.
Nakasatomi M; Kim H; Arai T; Hirako S; Shioda S; Iizuka Y; Sakurai K; Matsumoto A
Obes Res Clin Pract; 2018; 12(Suppl 2):29-38. PubMed ID: 27130153
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
[TBL] [Abstract][Full Text] [Related]
8. Impact of discontinuation of fish oil after pioglitazone-fish oil combination therapy in diabetic KK mice.
Iizuka Y; Chiba K; Kim H; Hirako S; Wada M; Matsumoto A
J Nutr Biochem; 2020 Feb; 76():108265. PubMed ID: 31760227
[TBL] [Abstract][Full Text] [Related]
9. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
Ghanaat-Pour H; Sjöholm A
Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
[TBL] [Abstract][Full Text] [Related]
10. Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice.
Arai T; Kim HJ; Chiba H; Matsumoto A
J Atheroscler Thromb; 2009 Oct; 16(5):674-83. PubMed ID: 19907107
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist.
Kanda Y; Shimoda M; Hamamoto S; Tawaramoto K; Kawasaki F; Hashiramoto M; Nakashima K; Matsuki M; Kaku K
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E278-86. PubMed ID: 19920213
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.
Diani AR; Sawada G; Wyse B; Murray FT; Khan M
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E116-22. PubMed ID: 14532171
[TBL] [Abstract][Full Text] [Related]
13. [The protection of islet β-cells in db/db mice by combination pioglitazone and glucagon like peptide-1 treatment].
Song LL; Xiao JZ; Yang WY; Zhang M; Liu BB; Pan L
Zhonghua Nei Ke Za Zhi; 2011 Sep; 50(9):781-4. PubMed ID: 22176969
[TBL] [Abstract][Full Text] [Related]
14. Colonic delivery of docosahexaenoic acid improves impaired glucose tolerance via GLP-1 secretion and suppresses pancreatic islet hyperplasia in diabetic KK-A(y) mice.
Shida T; Kamei N; Takeda-Morishita M; Isowa K; Takayama K
Int J Pharm; 2013 Jun; 450(1-2):63-9. PubMed ID: 23618969
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes.
Watanabe Y; Nakayama K; Taniuchi N; Horai Y; Kuriyama C; Ueta K; Arakawa K; Senbonmatsu T; Shiotani M
PLoS One; 2015; 10(1):e0116851. PubMed ID: 25615826
[TBL] [Abstract][Full Text] [Related]
16. Fish oil prevents excessive accumulation of subcutaneous fat caused by an adverse effect of pioglitazone treatment and positively changes adipocytes in KK mice.
Iizuka Y; Kim H; Nakasatomi M; Izawa T; Hirako S; Matsumoto A
Toxicol Rep; 2016; 3():4-14. PubMed ID: 28959521
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice.
Chu KY; Leung PS
Antioxid Redox Signal; 2007 Jul; 9(7):869-78. PubMed ID: 17508912
[TBL] [Abstract][Full Text] [Related]
18. Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.
Walter H; Lübben G
Drugs; 2005; 65(1):1-13. PubMed ID: 15610048
[TBL] [Abstract][Full Text] [Related]
19. Combination of Vildagliptin and Pioglitazone in Experimental Type 2 Diabetes in Male Rats.
Refaat R; Sakr A; Salama M; El Sarha A
Drug Dev Res; 2016 Sep; 77(6):300-9. PubMed ID: 27520857
[TBL] [Abstract][Full Text] [Related]
20. Protective potential of fish oil supplementation against insulin resistance and pancreatic islet damage in STZ-induced Wistar rats.
Titisari N; Fauzi A; Razak ISA; Samsulrizal N; Ahmad H
Open Vet J; 2023 Aug; 13(8):983-990. PubMed ID: 37701670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
